Temasek invests in Covid-19 testing specialist Molbio Diagnostics
Temasek will invest over ₹690 crore which will be used for domestic and external business development, overseas market expansion and research and development.
Temasek will invest over ₹690 crore which will be used for domestic and external business development, overseas market expansion and research and development.
India's vaccination rates remain sluggish; the number of daily Covid-19 tests has also waned considerably as the country faces an imminent threat from the Omicron variant.
The company claims that the kit can predict the prognosis of Covid-19 based on the profile of four genes, making it useful for the elderly and ones with co-morbidities.
The Reserve Bank of India kept the repo rate unchanged at 4% and maintained its policy stance as 'accommodative'. Here's how India Inc. reacted.
An earlier judgment by the apex court making Coronavirus tests free across the board had sparked concerns over the viability of the private sector’s participation in testing for the virus.
Following the South Korean model, players like SRL Diagnostics are setting up drive-through centres for sample collection to increase testing for Coronavirus by making it convenient for patients.